Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Quyushengxin Formula is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, affiliated with the Shanghai University of Traditional Chinese Medicine. It is primarily investigated for the treatment of ulcerative colitis (UC). The formula is designed based on the TCM principles of removing blood stasis and promoting tissue regeneration (Quyu Shengxin). In clinical trial ChiCTR2400082454, it is being evaluated for its efficacy and safety when used in combination with mesalazine for patients with ulcerative colitis. The mechanism likely involves anti-inflammatory and mucosal healing properties typical of TCM treatments for inflammatory bowel disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on quyushengxin formula.